Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Breast 5Tumor-Agnostic 4Thoracic 4Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 2Gynecologic 2Lymphoid 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 182Magnetic Resonance Spectroscopy 161Specimen Handling 134enzalutamide 125Nivolumab 118Gemcitabine 96Docetaxel 92Radiosurgery 91Prednisone 81Androgen Antagonists 81Abiraterone Acetate 79Radiotherapy 75apalutamide 66Cisplatin 65darolutamide 62Ipilimumab 61Biopsy 61abiraterone 57cabozantinib 55Carboplatin 55Leuprolide 52enfortumab vedotin 50Radiation 47Pluvicto 45Standard of Care 44atezolizumab 41Surveys and Questionnaires 38acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37avelumab 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Focus Groups × Genitourinary × 1 year × Clear all
NCT07407686 2026-02-12

INCLUDE PC

Royal Marsden NHS Foundation Trust

Not yet recruiting
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT06535802 2026-01-20

iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men

Mayo Clinic

Recruiting
53 enrolled
Genitourinary

Prostatic Neoplasms

NCT07091565 2025-08-03

SPARC

King's College London

Enrolling by invitation
60 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡